Fri, June 7, 2024
Thu, June 6, 2024
Wed, June 5, 2024
Tue, June 4, 2024
Mon, June 3, 2024
Fri, May 31, 2024

Balaji Prasad Maintained (TEVA) at Buy with Increased Target to $21 on, Jun 5th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-21-on-jun-5th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Balaji Prasad of Barclays, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Buy with Increased Target from $20 to $21 on, Jun 5th, 2024.

Balaji has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with Balaji's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Upgraded from Sell to Hold and Held Target at $14 on, Friday, March 8th, 2024
  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Increased Target to $11 on, Monday, February 5th, 2024


These are the ratings of the 2 analyists that currently disagree with Balaji


  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $21 on, Thursday, May 30th, 2024
  • David Amsellem of "Piper Sandler" Reiterated at Buy with Increased Target to $20 on, Monday, May 13th, 2024

Publication Contributing Sources